Aktualności

Wybierz wydział

Niedawno zaktualizowane rekordy

• Propofol and sevoflurane anesthesia in early childhood do not influence seizure threshold in adult rats. [AUT. KORESP.] PAWEŁ PIWOWARCZYK, [AUT.] ELŻBIETA RYPULAK, JUSTYNA SYSIAK-SŁAWECKA, DOROTA NIEOCZYM, KATARZYNA SOCAŁA, ALEKSANDRA WLAŹ, PIOTR WLAŹ, WALDEMAR TURSKI, MIROSŁAW CZUCZWAR, MICHAŁ BORYS. Int. J. Environ. Res. Public Health [online] 2021 vol. 18 nr 23 [art. nr] 12367, s. 1-11, bibliogr. poz. 52, [przeglądany 25 listopada 2021]. Dostępny w: https://www.mdpi.com/1660-4601/18/23/12367. DOI: 10.3390/ijerph182312367
  12.02.2026 18:42 • 2021
• Dual-action strategy to reprogram chaperone activity for α-synuclein aggregate clearance in Parkinson's disease. [AUT. KORESP.] OLIWIA KOSZŁA, [AUT.] PRZEMYSŁAW SOŁEK, JOANNA DEPCIUCH, MACIEJ MAJ. Int. J. Biol. Macromol. [online] 2026 vol. 347 [art. nr] 150730, s. 1-14, bibliogr. poz. 27, [przeglądany 5 lutego 2026]. Dostępny w: https://www.sciencedirect.com/science/article/pii/S0141813026006562?via%3Dihub. DOI: 10.1016/j.ijbiomac.2026.150730
  12.02.2026 13:13 • 2026
• I Ogólnopolska Konferencja Naukowa : Oblicza psychiatrii w farmacji i opiece farmaceutycznej. Lublin, 5-6 grudnia 2025 [online]. Streszcz. [RED.] ANNA SEREFKO, ALEKSANDRA SZOPA, ANNA KIJEWSKA, JAN SOBCZYŃSKI, KATARZYNA ŚWIĄDER, JOANNA LACHOWICZ-RADULSKA, FILIP NOWACZYŃSKI, ALICJA SZAFRAŃSKA, BEATA SWATOWSKA. Lublin 2026, Zakład Farmacji Klinicznej i Opieki Farmaceutycznej Uniwersytet Medyczny w Lublinie, ss. 59.
  12.02.2026 13:07 • 2026
• Characterisation of cytotoxicity-related receptors on γδ T cells in chronic lymphocytic leukaemia. [AUT. KORESP.] MICHAŁ ZAROBKIEWICZ, [AUT.] NATALIA LEHMAN, IZABELA MORAWSKA-MICHALSKA, ADAM MICHALSKI, WIOLETA KOWALSKA, AGATA SZYMAŃSKA, WALDEMAR TOMCZAK, AGNIESZKA BOJARSKA-JUNAK. Cells [online] 2025 vol. 14 nr 6 [art. nr] 451, s. 1-13, bibliogr. poz. 49, [przeglądany 18 marca 2025]. Dostępny w: https://www.mdpi.com/2073-4409/14/6/451. DOI: 10.3390/cells14060451
  12.02.2026 13:05 • 2025
• Tryptophan metabolites clearance in hemodialyzed patients. [AUT. KORESP.] IZABELA ZAKROCKA, [AUT.] RADOSŁAW MLAK, NATALIA MONICZEWSKA, SYLWIA BOCZKOWSKA, RENATA KLOC, TOMASZ KOCKI, EWA M. URBAŃSKA, WOJCIECH ZAŁUSKA, ANDREAS KRONBICHLER. Amino Acids [online] 2026 s. 1-33, bibliogr. poz. 45, [przeglądany 9 lutego 2026]. Dostępny w: https://link.springer.com/article/10.1007/s00726-026-03499-0. DOI: 10.1007/s00726-026-03499-0
  12.02.2026 13:01 • 2026
• Epidemiological characteristics of treated multiple sclerosis patients - Lublin experience (South-Eastern Poland). [AUT.] JULIA LEWTAK, KAMIL SYGA, [AUT. KORESP.] ANNA JAMROZ-WIŚNIEWSKA, [AUT.] WERONIKA KLESZCZYŃSKA, MONIKA MAZURKIEWICZ-KANAR, TOMASZ HASIEC, KONRAD REJDAK. Ann. Agric. Environ. Med. [online] 2025 vol. 32 nr 4 s. 566-571, bibliogr. poz. 25, [przeglądany 16 maja 2025]. Dostępny w: https://www.aaem.pl/Epidemiological-characteristics-of-treated-multiple-sclerosis-patients-Lublin-experience,204100,0,2.html. DOI: 10.26444/aaem/204100
  12.02.2026 12:58 • 2025
• Safety profile of anti-ageing natural cosmetic formulations with Litsea cubeba essential oil. [AUT.] DOMINIKA KOWALCZYK, ŁUKASZ ŚWIĄTEK, GOKHAN ZENGIN, ELWIRA SIENIAWSKA, [AUT. KORESP.] KATARZYNA BOROWSKA. Nasza Dermatol. Online [online] 2025 vol. 16 nr 3 s. 242-248, bibliogr. poz. 26, [przeglądany 2 lipca 2025]. Dostępny w: https://www.odermatol.com/issue-in-html/2025-3-4-natural_cosmetic/DOI: 10.7241/ourd.20253.4.
  12.02.2026 10:15 • 2025
• Epicardial adipose tissue mediates the association between circulating hsa-miR-4750-3p and coronary artery disease in patients with type 2 diabetes mellitus. [AUT. KORESP.] JOANNA SZYDEŁKO, [AUT.] TOMASZ ZAPOLSKI, MONIKA LENART-LIPIŃSKA, MARCIN CZOP, ALICJA PETNIAK, JANUSZ KOCKI, BEATA MATYJASZEK-MATUSZEK. Cardiovasc. Diabetol. [online] 2026 vol. 25 [art. nr] 39, s. 1-20, bibliogr. poz. 94, [przeglądany 11 lutego 2026]. Dostępny w: https://link.springer.com/article/10.1186/s12933-025-03055-2. DOI: 10.1186/s12933-025-03055-2
  12.02.2026 09:54 • 2026
• Global view of ocular parameter changes induced by a single hemodialysis session. [AUT. KORESP.] JOANNA ROSKAL-WAŁEK, JOANNA GOŁĘBIEWSKA, [AUT.] JERZY MACKIEWICZ, KAMILA BOŁTUĆ-DZIUGIEŁ, AGNIESZKA BOCIEK, PAWEŁ WAŁEK, DOMINIK ODROBINA, ANDRZEJ JAROSZYŃSKI. J. Clin. Med. [online] 2026 vol. 15 nr 2 [art. nr] 592, s. 1-15, bibliogr. poz. 26, [przeglądany 9 lutego 2026]. Dostępny w: https://www.mdpi.com/2077-0383/15/2/592. DOI: 10.3390/jcm15020592
  12.02.2026 09:51 • 2026
• Clinical and microbiological profile of oral candidiasis: a retrospective study. [AUT. KORESP.] MAJA PTASIEWICZ, [AUT.] KAROLINA THUM-TYZO, ALICJA MATEJKO, JULIA GEORGES, EMANUELA BIS, ALEKSANDRA STRĄCZEK, RENATA CHAŁAS, AGNIESZKA MAGRYŚ. Pathogens [online] 2026 vol. 15 nr 2 [art. nr] 195, s. 1-11, bibliogr. poz. 37, [przeglądany 10 lutego 2026]. Dostępny w: https://www.mdpi.com/2076-0817/15/2/195. DOI: 10.3390/pathogens15020195
  12.02.2026 09:47 • 2026
• Trendy w obszarze działalności eksperckiej i dydaktycznej uniwersyteckich zakładów medycyny sądowej w latach 2011-2024. (Trends in the expert and teaching activities of university forensic medicine departments in 2011-2024.). [AUT.] GRZEGORZ TERESIŃSKI. Arch. Med. Sąd. 2025 t. 75 nr 4 s. 292-313, bibliogr. poz. 70, sum. DOI: 10.4467/16891716AMSIK.25.021.23213
  12.02.2026 08:30 • 2025
• Ocena stanu wiedzy pacjentów na temat zespołu stopy cukrzycowej. (Assessment of patients’ knowledge about diabetic foot syndrome.). [AUT.] MONIKA PRUCHNIAK, AGNIESZKA SOBOLEWSKA-SAMOREK, WITOLD ZGODZIŃSKI, ROBERT J. ŁUCZYK, AGNIESZKA WAWRYNIUK, MARTA ŁUCZYK, ANNA HORDYJEWSKA, ALINA TROJANOWSKA, MACIEJ KACZKOWSKI, KAMIL SIKORA, DOROTA WEBER. W: Psychospołeczny i somatyczny wymiar opieki medycznej sprawowanej nad człowiekiem zdrowym i chorym [online]. Red. nauk. Robert J. Łuczyk, Dorota Weber, Marta Łuczyk, Andrzej Tytuła, Kamil Sikora, Agnieszka Wawryniuk Lublin 2025, Innovatio Press, s. 16-26, bibliogr. poz. 22 sum, [przeglądany 6 lutego 2026]. Dostępny w: https://wydawnictwo.wsei.eu/sklep/psychospoleczny-i-somatyczny-wymiar-opieki-medycznej-sprawowanej-nad-czlowiekiem-zdrowym-i-chorym-e-book/.
  12.02.2026 08:28 • 2025

Najnowsze rekordy ze streszczeniem

• Safety profile of anti-ageing natural cosmetic formulations with Litsea cubeba essential oil. [AUT.] DOMINIKA KOWALCZYK, ŁUKASZ ŚWIĄTEK, GOKHAN ZENGIN, ELWIRA SIENIAWSKA, [AUT. KORESP.] KATARZYNA BOROWSKA. Nasza Dermatol. Online [online] 2025 vol. 16 nr 3 s. 242-248, bibliogr. poz. 26, [przeglądany 2 lipca 2025]. Dostępny w: https://www.odermatol.com/issue-in-html/2025-3-4-natural_cosmetic/DOI: 10.7241/ourd.20253.4.
  Background: Litsea cubeba, also known as mountain pepper, belongs to the Lauraceae family. It has been used as a traditional herbal medicine since approximately 600 A.D., for example, in traditional Chinese medicine to treat inflammation, headaches, and intoxication. Essential oil extracted from the fresh fruits of Litsea cubeba is a clear, oily liquid with various activities, including antimicrobial, antioxidant, anticancerous, anti-inflammatory, and anti-diabetic properties. L. cubeba fruit has demonstrated cytotoxic effects on human lung, liver, and oral cancer cells. It is also shown to inhibit tyrosinase and reduce melanin production in epidermal cells, leading to decreased discoloration and skin aging. Aim: The objective of this study is to provide a comprehensive report regarding the chemical composition and safety profiles, as well as the antioxidant and anti-tyrosinase activities, of Litsea cubeba …
• Global view of ocular parameter changes induced by a single hemodialysis session. [AUT. KORESP.] JOANNA ROSKAL-WAŁEK, JOANNA GOŁĘBIEWSKA, [AUT.] JERZY MACKIEWICZ, KAMILA BOŁTUĆ-DZIUGIEŁ, AGNIESZKA BOCIEK, PAWEŁ WAŁEK, DOMINIK ODROBINA, ANDRZEJ JAROSZYŃSKI. J. Clin. Med. [online] 2026 vol. 15 nr 2 [art. nr] 592, s. 1-15, bibliogr. poz. 26, [przeglądany 9 lutego 2026]. Dostępny w: https://www.mdpi.com/2077-0383/15/2/592. DOI: 10.3390/jcm15020592
  Background/Objectives: Hemodialysis (HD) is the commonest life sustaining form of kidney replacement therapy in the world; however, this method of treatment have many adverse effects, and even a single HD session affects many organs, including the eyes. The aim of this study was to assess the effect of a single HD session on the ophthalmologic findings in patients with End-stage Renal Disease (ESRD). The second aim of the study was to examine the correlation of these changes with each other and between changes in systemic stressors related to the HD session. Methods: This was a single-center cross-sectional observational study conducted on 32 patients undergoing HD. Selected parameters of the anterior and posterior segment of the eye as well as systemic parameters were assessed before and after a single HD session. …
• Exploring the therapeutic potential of Cousinia iconica Hub.-Mor extracts through chemical profiling, in vitro and in-silico assays. [AUT.] BENITA HRYĆ, GUNES AK, [AUT. KORESP.] SAKINA YAGI, [AUT.] ELWIRA SIENIAWSKA, ŁUKASZ ŚWIĄTEK, KINGA SALWA, MEHMET VEYSI CETIZ, EVREN YILDIZTUGAY, STEFANO DALL’ACQUA, GOKHAN ZENGIN. J. Agric. Food Res. [online] 2026 vol. 26 [art. nr] 102678, s. 1-23, bibliogr. poz. 70, [przeglądany 19 stycznia 2026]. Dostępny w: https://www.sciencedirect.com/science/article/pii/S2666154326000487. DOI: 10.1016/j.jafr.2026.102678
  Abstract Some species of the genus Cousinia (family Asteraceae) are traditionally used to treat various diseases, and scientific research has demonstrated that they possess interesting biological activities. This study offers the first comprehensive evaluation of the aerial parts of Cousinia iconica Hub.-Mor, incorporating phytochemical profiling, bioactivity assays, and network pharmacology. High-resolution LC–ESI-QTOF–MS analysis revealed that the plant is rich in phenolic acids, hydroxy- and methoxy-flavonoid glycosides, and lignans. The aqueous extract contained the highest levels of total phenolics (78 mg gallic acid equivalents/g) and flavonoids (15.5 mg rutin equivalents/g). It also exhibited the strongest radical scavenging, reducing power, and metal chelating activities. Biological tests showed that, while all three organic extracts had similar cytotoxic effects against the RKO colorectal cancer cell line, none demonstrated measurable antiviral activity against HHV-1 or …
• Overtraining syndrome - what we already know. [AUT.] ŁUKASZ BRYLIŃSKI, FILIP WOLIŃSKI, PIOTR DUDA, PAULINA DROŻAK, KATARZYNA KOSTELECKA, JACEK BAJ. J. Educ. Health Sport [online] 2022 vol. 12 nr 6 s. 192-204, bibliogr. poz. 50, [przeglądany 13 lipca 2022]. Dostępny w: https://apcz.umk.pl/JEHS/article/view/38734.
  Introduction: Overtraining syndrome (OTS) is a state of excess sportsmen's overload caused by too high an intensity of training. The main cause of OTS is too big a training load. Also, they are other risk factors like restrictive diets, inordinate stress, and inflated expectations of a family and a coach. Description of the state of knowledge: despite numerous hypotheses like dysregulation of hypothalamus and pituitary, inflammatory hypothesis, and glycogen hypothesis the exact cause of OTS is not fully understood. None of these hypotheses explains completely all of the symptoms. In diagnosis, several laboratory tests are required to exclude other diseases. After it, because of possible systemic character diagnostic process of OTS is still problematic. One of the diagnostic methods relies on the measurement of hormone levels. Another potential diagnostic method …
• Experimental models and translational strategies in neuroprotective drug development with emphasis on Alzheimer’s disease. [AUT.] PRZEMYSŁAW NIZIŃSKI, KAROLINA SZALAST, ANNA MAKUCH-KOCKA, KINGA PARUCH-NOSEK, MAGDALENA CIECHANOWSKA, [AUT. KORESP.] TOMASZ PLECH. Molecules [online] 2026 vol. 31 nr 2 [art. nr] 320, s. 1-44, bibliogr. poz. 359, [przeglądany 3 lutego 2026]. Dostępny w: https://www.mdpi.com/1420-3049/31/2/320. DOI: 10.3390/molecules31020320
  Neurodegenerative diseases (NDDs), including Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), are becoming more prevalent and still lack effective disease-modifying therapies (DMTs). However, translational efficiency remains critically low. For example, a ClinicalTrials.gov analysis of AD programs (2002–2012) estimated ~99.6% attrition, while PD programs (1999–2019) achieved an overall success rate of ~14.9%. In vitro platforms are assessed, ranging from immortalized neuronal lines and primary cultures to human-induced pluripotent stem cell (iPSC)-derived neurons/glia, neuron–glia co-cultures (including neuroinflammation paradigms), 3D spheroids, organoids, and blood–brain barrier (BBB)-on-chip systems. Complementary in vivo toxin, pharmacological, and genetic models are discussed for systems-level validation and central nervous system (CNS) exposure realism. The therapeutic synthesis focuses on AD, covering symptomatic drugs, anti-amyloid immunotherapies, tau-directed approaches, and repurposed drug classes that target …